Learning Objectives
Upon completion of this activity, participants should be able to:
- Identify management strategies for persons who were previously treated with interferon-based and ribavirin therapy
- Discuss study results concerning the retreatment of HCV-infected persons previously nonresponsive to antiviral therapy
- Describe data concerning treatment approaches using novel agents in development for HCV-infected persons previously nonresponsive to antiviral therapy
CCO Virtual Presentations combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.